抑郁症的仪器检测技术及其研究进展OA
Development Progress of Instrumental Analysis Technologies for Detection of Depression
抑郁症作为全球性公共健康问题,具有发病率高、人群分布广泛、危害性显著及临床诊断难度大等特点,对患者及其家庭的工作、学习与生活质量造成严重影响,甚至可能危及患者自身及他人的生命安全.传统的临床诊断方法主要依赖访谈与问卷评估,存在显著的客观性缺陷,且难以对患者症状的严重程度进行量化表征.近年来,随着抑郁症病理机制研究的深入,研究者发现其发病与特定生物学指标变化密切相关,如中枢神经递质、外周炎症因子及体内代谢产物等潜在生物标志物,为发展客观、量化的精准诊断方法提供了理论基础.基于此,研究者开发了多种检测技术(包括生物标志物检测)用于抑郁症诊断或辅助诊断.本文系统总结了色谱技术、质谱技术、光谱技术、电化学传感技术、磁共振成像技术及可穿戴传感器技术在抑郁症筛查与诊断领域的最新研究与应用进展,归纳了可能用于抑郁症精准诊断的潜在生物标志物,分析了各技术的优势及其临床应用价值,并对其未来的发展方向进行了展望.
Depression has become a universal public health challenge worldwide.Traditional diagnostic methods relying on clinical interviews and questionnaires often have strong subjectivity and lack clear biomarkers.In recent years,with the deepening understanding of the pathophysiological mechanisms of depression,accumulating evidence has demonstrated that depression is closely associated with alterations in specific biological indicators,including central neurotransmitters,peripheral inflammatory factors,and endogenous metabolic products,which may serve as potential biomarkers.These findings provide a solid theoretical foundation for the development of objective and quantitative precision diagnostic methods.Accordingly,a variety of detection technologies,including biomarker-based assays,have been actively explored for the objective diagnosis and auxiliary diagnosis of depression.These developments highlight the urgent clinical demand for diagnostic technologies that are rapid,objective,and highly accurate.Future research efforts therefore need to focus on the development of novel diagnostic technologies for depression which are rapid,sensitive,objective,and quantifiable.This paper systematically reviews the latest applications of chromatography,mass spectrometry,spectroscopy,electrochemical techniques,magnetic resonance imaging,and wearable sensor technologies in the screening and diagnosis of depression.It summarizes the potential biomarkers that may be useful for the precise diagnosis of depression,discusses the advantages and clinical applicability of each technology,and analyzes their future development trends and prospects.Notably,technologies such as mass spectrometry,particularly when integrated with multimodal detection approaches and artificial intelligence techniques,are expected to drive depression diagnostics toward more precise and non-invasive directions.Therefore,the future development of technologies and devices focusing on early screening,non-invasive detection,convenient diagnosis,and precise evaluation of depression is of great importance,as it will provide critical support for clinical intervention and prognosis improvement,and holds substantial academic value and translational clinical significance.
隋华杰;郭雨虹;朱腾高;刘悦翔;方小伟;王国兵;陈焕文
江西中医药大学人文学院,南昌 330004江西中医药大学人文学院,南昌 330004江西中医药大学,恶性肿瘤中医药诊疗与康复江西省重点实验室,南昌 330004江西中医药大学人文学院,南昌 330004||山东省戴庄医院,济宁 272051江西中医药大学,恶性肿瘤中医药诊疗与康复江西省重点实验室,南昌 330004江西中医药大学,恶性肿瘤中医药诊疗与康复江西省重点实验室,南昌 330004江西中医药大学,恶性肿瘤中医药诊疗与康复江西省重点实验室,南昌 330004
抑郁症仪器检测技术生物标志物多模态研究进展评述
DepressionInstrumental detection technologyBiomarkersMultimodalityResearch progressReview
《分析化学》 2026 (2)
171-182,中插1-中插2,14
国家自然科学基金项目(No.22376084)、江西中医药大学校级科技创新团队发展项目(No.CXTD22005)、江西省科学技术厅管理科学项目(No.20252BAA100023)和济宁市重点研发计划项目(No.2024YXNS201)资助. Supported by the National Natural Science Foundation of China(No.22376084),the Jiangxi University of Chinese Medicine School-level Science and Technology Innovation Team Development Program(No.CXTD22005),the Management Science Project of Jiangxi Provincial Department of Science and Technology(No.20252BAA100023)and the Jining Key Research and Development Program(No.2024YXNS201).
评论